Bharat Book

Trends in Therapeutic Partnering

Press Release   •   Dec 14, 2013 09:26 IST

Dec 14, 2013 : Bharat Book Bureau presents the new report, on 'Trends in Therapeutic Partnering'  provides a detailed understanding and analysis of the most popular therapeutic targets for partnering in the period 2007 to mid 2013. The majority of deals are discovery, preclinical and clinical stage whereby the licensee obtains a right or an option right to license or access the licensors compounds or product candidates. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.

One of the key aspects of partnering is finding those companies that are potential candidates for the development and commercialization of the next generation of therapeutic targets. A lot of resources are spent on finding partners, identifying their interests and making contact to initiate discussions.

Using this report, dealmakers will effectively and efficiently target their partnering activities to deliver the company’s business development objectives. Over 300 charts allow quick understanding of therapeutic partnering trends since 2007, together with insight into which companies are active in each of the thirty five leading therapeutic areas.

Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered – contract documents provide this insight where press releases and databases do not.

The initial chapters of this report provide an orientation of therapeutic dealmaking.

Chapter 1 provides an introduction to the report, whilst chapter 2 provides an overview of therapeutic dealmaking since 2007, listing the top therapeutic areas for partnering by deal frequency and deal dollars committed by partnering companies.

Chapter 3 reviews the top pharma and biotech therapeutic partnering deals of 2007-2013 according to reported deal size.

Chapter 4 provides a summary on best practice on how to submit an opportunity to the leading therapeutic partnering companies, to ensure building of relationships and to obtain a prompt assessment and response from the business development function of the prospective partner.

Chapter 5 lists forthcoming partnering events where valuable face to face meetings with big biotech provide a highly effective means of obtaining interest in novel opportunities. These events are where dealmaking gets initiated through numerous back to back meetings.

The main body of the report is provided in chapter 6. In-depth profiles of each of the top 35 therapeutic target areas according to deal frequency during the period 2007-2013 provide everything required to assess the potential of the therapeutic area and its active partner companies. Each profile includes a partnering activity overview, deal financials (including headline, upfront and royalties rates, where available).

Each therapeutic profile provides a listing of partnering deals for the top fifiteen most active companies in each therapeutic area, and is accompanied by an appendix that provides a comprehensive listing of deal records available at Current Agreements, each of which links direct to an online copy of the actual deal record plus contract document if filed with the SEC.

One of the key aspects of partnering is conducting due diligence on a partner to determine under what terms a prospective partner agrees to a partnering relationship.

Understanding the flexibility of a prospective partners’ negiotated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered – contract documents provide this insight where press releases and databases do not.

This data driven report contains over 5,000 links to online copies of actual deal records at Current Agreements and contract documents, where submitted to the Securities Exchange Commission by companies and their partners. Contract documents provide the answers to numerous questions about a prospective partner’s flexibility on a wide range of important issues, many of which will have a significant impact on each party’s ability to derive value from the deal.

In addition, contract documents provide the answers to numerous questions about a prospective partner’s flexibility on a wide range of important issues, many of which will have a significant impact on each party’s ability to derive value from the deal.

In summary, the report provides the reader with the tools necessary to understand trends in therapeutic partnering, the most active therapeutic areas in terms of deal frequency and leading deal maker companies, and the deal terms and structures achieved in such therapeutic partnering deals.

Benefits

Trends in Therapeutic Partnering provides the reader with the following key benefits:

In-depth understanding of therapeutic partnering trends since 2007
Analysis of the top 35 therapeutic target areas for partnering
Comprehensive access to over 5,000 actual partnering deals entered into by the world’s biopharma companies
Detailed access to actual therapeutic partnering deals enter into by the leading fifty bigpharma and bigbiotech companies
Insight into the terms included in a therapeutic partnering agreement, together with real world clause examples
Understand the key deal terms companies have agreed in previous deals
Undertake due diligence to assess suitability of your proposed deal terms for partner companies

Report scope

Trends in Therapeutic Partnering is intended to provide the reader with an in-depth understanding of therapeutic partnering trends and structure of deals entered into by leading companies worldwide.

Trends in Therapeutic Partnering includes:

Trends in therapeutic dealmaking in the biopharma industry since 2007
Analysis of therapeutic partnering deal structure
Access to over 5,000 therapeutic partnering deals
The top 35 therapeutic targets for partnering since 2007
The leading therapeutic partnering deals by value since 2007
Most active therapeutic partnering dealmakers since 2007

In Trends in Therapeutic Partnering, the available deals are listed by:

Most active companies in partnering for each therapeutic area
Headline value
Upfront payment
Royalty rate
Company A-Z

Table of Contents :


Executive Summary

Chapter 1 – Introduction

Chapter 2 – Trends in therapeutic dealmaking activity
2.1. Introduction
2.2. Leading therapy partnering areas
2.3. Top therapeutic targets for partnering 2007-2013

Chapter 3 – Leading therapy deals by value
3.1. Introduction
3.2. Big pharma therapy partnering
3.3. Big biotech therapy partnering

Chapter 4 – Submitting Opportunities to therapeutic target partner companies
4.1. How to submit an opportunity
4.2. Opportunity submission template
4.3. Sending emails
4.4. Face to face at partnering events
4.5. Online submission forms

Chapter 5 – Forthcoming therapeutic partnering events
5.1. Forthcoming events

Chapter 6 – Top 35 therapeutic partnering targets
6.1. Introduction
6.2. Therapeutic profiles
Diabetes
Diabetes partnering in numbers
Top diabetes partnering deals by value
Most active diabetes partnering companies
Pain
Pain partnering in numbers
Top pain partnering deals by value
Most active pain partnering companies
Breast cancer
Breast cancer partnering in numbers
Top breast cancer partnering deals by value
Most active breast cancer partnering companies
Influenza
Influenza partnering in numbers
Top influenza partnering deals by value
Most active influenza partnering companies
HIV
HIV partnering in numbers
Top HIV partnering deals by value
Most active HIV partnering companies
Alzheimer’s disease
Alzheimer’s disease partnering in numbers
Top Alzheimer’s disease partnering deals by value
Most active Alzheimer’s disease partnering companies
Inflammation
Inflammation partnering in numbers
Top Inflammation partnering deals by value
Most active inflammation partnering companies
Prostate cancer
Prostate cancer partnering in numbers
Top prostate cancer partnering deals by value
Most active prostate cancer partnering companies
Wound healing
Wound healing partnering in numbers
Top wound healing partnering deals by value
Most active wound healing partnering companies
Leukemia
Leukemia partnering in numbers
Top leukemia partnering deals by value
Most active leukemia partnering companies
Lung cancer
Lung cancer partnering in numbers
Top lung cancer partnering deals by value
Most active lung cancer partnering companies
Nutrition
Nutrition partnering in numbers
Top nutrition partnering deals by value
Most active nutrition partnering companies
Rheumatoid arthritis
Rheumatoid arthritis partnering in numbers
Top rheumatoid arthritis partnering deals by value
Most active rheumatoid arthritis partnering companies
Colorectal cancer
Coloractal cancer partnering in numbers
Top colorectal cancer partnering deals by value
Most active colorectal cancer partnering companies
Solid tumor
Solid tumor partnering in numbers
Top solid tumors partnering deals by value
Most active solid tumor partnering companies
Hepatitis C
Hepatitis C partnering in numbers

For more information kindly visit : http://www.bharatbook.com/healthcare-market-research-reports/trends-in-therapeutic-partnering.html

Related link :  http://www.bharatbook.com/market-research-report/pharmaceuticals-and-healthcare.html

About Bharat Book Bureau:

Bharat Book Bureau is the leading market research information provider for market research reports, , company profiles, industry analysis , country reports , business reports, newsletters and online databases Bharat Book Bureau provides over a million reports from more than 400 publishers around the globe. We cover sectors starting from Aeronautics to Zoology.

In case the reports don't match your requirement then we can do a specialized Custom Research for you. Our multifarious capabilities, cross-sector expertise and detailed knowledge of various markets, put us in a unique position to take up Custom Research demands of yourself.

Contact us at :

Bharat Book Bureau
Tel: +91 22 27810772 / 27810773
Toll Free No for USA/Canada : 1-866-279-8368
Email: info@bharatbook.com 
Website: www.bharatbook.com 
Follow us on twitter: https://twitter.com/researchbook 
Follow us on linked in : http://www.linkedin.com/company/bharat-book-bureau 
Our Blog : http://blog.bharatbook.com/ 


Bharat Book Bureau, the leading market research information aggregator provides market research reports, company profiles, country reports, newsletters, and online databases for the past twenty four years to corporate, consulting firms, academic institutions, government departments, agencies etc., globally, including India. Our market research reports help global companies to know different market before starting up business / expanding in different countries across the world.